Cannabidiol Market Soars to USD 36.6 Billion by 2033 || Growing Demand For Personal Care Products
December 11, 2023 02:52 ET
|
Market.Us
New York, Dec. 11, 2023 (GLOBE NEWSWIRE) -- According to the market.us, the global Cannabidiol Market Size was valued at USD 7.6 billion in 2023 and is anticipated to reach approximately USD 36.6...
New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
November 24, 2023 08:55 ET
|
SciSparc Ltd
TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
[Latest] Global Cannabidiol Market Size/Share Worth USD 19.67 Billion by 2032 at a 18% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
October 26, 2023 00:30 ET
|
Custom Market Insights
Austin, TX, USA, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cannabidiol Market Size, Trends and Insights By Source Type (Hemp, Marijuana),...
Global CBD Market Set to Surge to $6.17 Billion in 2023, Propelled by Growing Awareness of Medicinal Benefits and Increasing Regulatory Approvals
October 09, 2023 07:53 ET
|
Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Cannabidiol (CBD) Market (by Product, Source, End User, Distribution Channel, & Region): Insights and Forecast with Potential Impact of...
Global Cannabidiol (CBD) Market Report 2023-2027 & 2032 Featuring Major Players - ENDOCA, Cannoid, Medical Marijuana, Inc, Folium Biosciences, & Elixinol
October 03, 2023 04:53 ET
|
Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Cannabidiol Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global cannabidiol market grew from $6.82...
CBD Gummies Market Size Will Attain USD 19.4 Billion by 2030 Registering a Promising CAGR of 29.2% - Exclusive Report by Zion Market Research | Global Cannabidiol (CBD) Gummies Market Size, Share, Trends Analysis Report
August 24, 2023 15:08 ET
|
Zion Market Research
SAN FRANCISCO, U.S., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “CBD Gummies Market By Concentration (Low And High), By Distribution Channel...
VPR Brands Announces Q2 2023 and Year to Date Financial Results
August 16, 2023 08:22 ET
|
VPR Brands LP
FORT LAUDERDALE, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- via IBN -- VPR Brands LP (OTC: VPRB) a licensing company owning patents and trademarks as well as a market leader for the design and sale of...
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
July 26, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
July 14, 2023 07:55 ET
|
SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
July 13, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...